Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Takanori Suzuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B Surface Antigens, RNA, Viral, Hepatitis B virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Hepatitis B virus (HBV) RNA and hepatitis B core‐related antigen (HBcrAg) have been reported to reflect the transcriptional activity of covalently closed circular HBV DNA. We retrospectively investigated the proportions of quantifiable serum HBV RNA and immunoassay for total antigen including complex via pretreatment‐hepatitis B core‐related antigen (iTACT‐HBcrAg) in chronic hepatitis B patients negative for hepatitis B e antigen (HBeAg) and/or with hepatitis B surface antigen (HBsAg) seroclearance. This study included 246 HBeAg‐negative HBV‐infected patients, who comprised 13 with liver cirrhosis (LC, the LC group), 118 chronic hepatitis (CH, the CH group), and 115 inactive carriers (IC, the IC group), and 44 patients with HBsAg seroclearance. iTACT‐HBcrAg and HBV RNA levels were determined using stored serum samples. Higher proportions of the patients had quantifiable iTACT‐HBcrAg than HBV RNA in all groups of HBeAg‐negative patients (iTACT‐HBcrAg: 84.6%, 90.7%, 35.7%, HBV RNA: 23.1%, 26.3%, 14.8%, for the LC, CH, IC groups). With HBsAg seroclearance (HBsAg
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Clinical Laboratory Medicine, Nagoya City University Hospital, Nagoya, Japan.
- Department of Central Inspection, Kumamoto University, Kumamoto, Japan.
- Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan.
ORCID-Profile: Kentaro Matsuura
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Suzuki, T., Matsuura, K., Inoue, T., Sasada, K., Ogawa, S., Watanabe, T., Kawamura, H., Fujiwara, K., Kataoka, H., & Tanaka, Y. (2024). Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients. Journal of Medical Virology. https://doi.org/10.1002/jmv.29816
Vancouver
Suzuki T, Matsuura K, Inoue T, Sasada K, Ogawa S, Watanabe T, et al. Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients. Journal of Medical Virology. 2024. doi:10.1002/jmv.29816
BibTeX
@article{Suzuki2024,
author = {Suzuki, Takanori and Matsuura, Kentaro and Inoue, Takako and Sasada, Keiko and Ogawa, Shintaro and Watanabe, Takehisa and Kawamura, Hayato and Fujiwara, Kei and Kataoka, Hiromi and Tanaka, Yasuhito},
title = {Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29816}
}
EUVIMED